Understanding Retnitis Pigmentosa through Ayurgenomics

Clicks: 1
ID: 311256
2025
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal

Ranked #18 of 34 articles by views in Journal of Clinical Advances and Research Reviews

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
Retinitis pigmentosa (RP) is a genetically diverse set of inherited retinal dystrophies characterized by progressive photoreceptor degradation, which causes night blindness, peripheral vision loss, and eventual blindness. Despite improvements in molecular genetics, conclusive cures are still lacking. Ayurgenomics, an emerging subject that combines Ayurveda's Prakriti-based constitutional framework with current genomics, offers a fresh way to determining individual vulnerability and therapeutic solutions. This review examines Retinitis Pigmentosa through the lens of Ayurgenomics, comparing traditional Ayurvedic descriptions of hereditary and degenerative ocular illnesses to genetic insights and proposing integrative approaches for early detection, risk assessment, and individualized care.
Reference Key
imported_1770374141_6985c3fdb5291 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Divyasri R N*, Sathisha Shankara B, Kavyashree R N
Journal Journal of Clinical Advances and Research Reviews
Year 2025
DOI
10.62896/jcarr.v2.i4.02
URL
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.